Caplacizumab是一种人源化 (vWF) 纳米抗体。Caplacizumab 抑制 vWF 介导的血小板粘附并防止进一步的。Caplacizumab 可用于（TTP）的相关研究。(Caplacizumab is a humanized nanoantibody against von Willebrand factor (vWF). Caplacizumab inhibits vWF-mediated platelet adhesion and prevents further microthrombosis. Caplacizumab can be used in the research of thrombotic thrombocytopenic purpura (TTP).)
